Barrington Research Maintains Outperform on TD Synnex, Raises Price Target to $202 Citigroup Maintains Neutral on Healthpeak Properties, Lowers Price Target to $17.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results